A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
NGM Biopharmaceuticals, Inc
Elevation Oncology
Alliance for Clinical Trials in Oncology
Stanford University
ADC Therapeutics S.A.
Cancer Research and Biostatistics Clinical Trials Consortium
Massachusetts General Hospital
pharmaand GmbH
Genmab
National Institutes of Health Clinical Center (CC)
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Gilead Sciences
Incyte Corporation
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Washington University School of Medicine
Dartmouth-Hitchcock Medical Center
University of Kansas Medical Center
Columbia University
Roswell Park Cancer Institute
Amgen
Fox Chase Cancer Center
Amgen
INSYS Therapeutics Inc
Altor BioScience
Massachusetts General Hospital